BackgroundCheck.run
Search For

Andrew J Mackinnon, 41Gales Ferry, CT

Related to:
Kathleen Elizabeth Mackinnon 46

Andrew Mackinnon Phones & Addresses

Gales Ferry, CT   

Niantic, CT   

604 Joanne Dr, San Mateo, CA 94402    650-6783531   

Minot AFB, ND   

Get Report
Control this profile

Mentions for Andrew J Mackinnon

Career records & work history

Medicine Doctors

Andrew L. Mackinnon

Specialties:
Cardiovascular Disease
Work:
WellmedWellmed At Crockett Park
1715 Mccullough Ave FL 2, San Antonio, TX 78212
210-2255323 (phone) 210-2257505 (fax)
Site
WellmedSpecialists For Health Cardiology
509 SW Military Dr STE 105, San Antonio, TX 78221
210-5580122 (phone) 210-5580120 (fax)
Site
Education:
Medical School
Medical College of Wisconsin School of Medicine
Graduated: 2000
Procedures:
Cardiac Catheterization, Echocardiogram
Conditions:
Acute Myocardial Infarction (AMI), Angina Pectoris, Atrial Fibrillation and Atrial Flutter, Cardiac Arrhythmia, Cardiomyopathy, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Heart Failure, Hypertension (HTN), Ischemic Heart Disease
Languages:
English, Spanish
Description:
Dr. Mackinnon graduated from the Medical College of Wisconsin School of Medicine in 2000. He works in San Antonio, TX and 1 other location and specializes in Cardiovascular Disease. Dr. Mackinnon is affiliated with Baptist Medical Center and Metropolitan Methodist Hospital.

Publications & IP owners

Us Patents

Combination Therapy With Glutaminase Inhibitors

US Patent:
2017033, Nov 23, 2017
Filed:
May 3, 2017
Appl. No.:
15/585523
Inventors:
- South San Francisco CA, US
Andrew L. MacKinnon - San Francisco CA, US
Mirna L. Rodriguez - San Jose CA, US
Dong Zhang - San Jose CA, US
Francesco Parlati - San Francisco CA, US
International Classification:
A61K 31/501
A61K 31/517
A61K 31/436
A61K 31/502
A61N 5/10
A61K 45/06
Abstract:
The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an anticancer agent such as an enzyme inhibitor (such as a kinase inhibitor), a mitotic inhibitor, a DNA-modifying agent, or a cytidine analog. The invention further relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases that are resistant to one or more anticancer agents.

Combination Therapy With Glutaminase Inhibitors

US Patent:
2016002, Jan 28, 2016
Filed:
Jun 12, 2015
Appl. No.:
14/738279
Inventors:
- South San Francisco CA, US
Andrew L. MacKinnon - San Francisco CA, US
Mirna L. Rodriguez - San Jose CA, US
Dong Zhang - San Jose CA, US
Francesco Parlati - San Francisco CA, US
International Classification:
A61K 31/501
A61N 5/10
A61K 31/436
A61K 31/517
A61K 45/06
A61K 31/502
Abstract:
The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an anticancer agent such as an enzyme inhibitor (such as a kinase inhibitor), a mitotic inhibitor, a DNA-modifying agent, or a cytidine analog. The invention further relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases that are resistant to one or more anticancer agents.

Possible Relatives

David P Mackinnon  Debra K Mackinnon  Daniel Mackinnon  Denise Mackinnon  Daryl L Mackinnon  Diana L Mackinnon  Donald N Mackinnon  Andrew T Last  Andrew R Johnson  Andrew P Stanco 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.